syndromes Coagulation activation and long-term outcome in acute coronary

[1]  R. Rosenberg,et al.  Regulation of Vascular Bed–Specific Prothrombotic Potential , 2001, Circulation research.

[2]  Jacqueline P Mitchell,et al.  Comparison of Novel Hemostatic Factors and Conventional Risk Factors for Prediction of Coronary Heart Disease , 2000, Circulation.

[3]  D. Ardissino,et al.  In Vivo Thrombin Generation and Activity During and After Intravenous Infusion of Heparin or Recombinant Hirudin in Patients With Unstable Angina Pectoris , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[4]  R. Rubin,et al.  A murine model of myocardial microvascular thrombosis. , 1999, The Journal of clinical investigation.

[5]  N. Tsopanoglou,et al.  On the Mechanism of Thrombin-induced Angiogenesis , 1999, The Journal of Biological Chemistry.

[6]  P. Mannucci,et al.  Plasma levels of activated protein C in healthy subjects and patients with previous venous thromboembolism: relationships with plasma homocysteine levels. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[7]  R. Califf,et al.  Thrombin generation, inhibition and clinical outcomes in patients with acute myocardial infarction treated with thrombolytic therapy and heparin: results from the GUSTO-I Trial. GUSTO-I Hemostasis Substudy Group. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries. , 1998, Journal of the American College of Cardiology.

[8]  D. Ardissino,et al.  Thrombin activity and early outcome in unstable angina pectoris. , 1996, Circulation.

[9]  J. Griffin.  The thrombin paradox , 1995, Nature.

[10]  C. Gibbs,et al.  Conversion of thrombin into an anticoagulant by protein engineering , 1995, Nature.

[11]  D. Ardissino,et al.  Persistent Activation of Coagulation Mechanism in Unstable Angina and Myocardial Infarction , 1994, Circulation.

[12]  C. Esmon,et al.  Antithrombotic effects of thrombin-induced activation of endogenous protein C in primates. , 1993, The Journal of clinical investigation.

[13]  J. Griffin,et al.  Direct detection of activated protein C in blood from human subjects. , 1992, Blood.

[14]  J. Griffin,et al.  Antithrombotic Effects of Combining Activated Protein C and Urokinase in Nonhuman Primates , 1991, Circulation.

[15]  P. Grambsch,et al.  Martingale-based residuals for survival models , 1990 .

[16]  P. Armstrong,et al.  Intracoronary thrombus and complex morphology in unstable angina. Relation to timing of angiography and in-hospital cardiac events. , 1989, Circulation.

[17]  K. Bauer,et al.  The pathophysiology of the prethrombotic state in humans: insights gained from studies using markers of hemostatic system activation. , 1987, Blood.

[18]  M. Davies,et al.  Intramyocardial platelet aggregation in patients with unstable angina suffering sudden ischemic cardiac death. , 1986, Circulation.

[19]  D. Beeler,et al.  Detection of protein C activation in humans. , 1984, The Journal of clinical investigation.

[20]  M. Simoons.  A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes. , 1996, The New England journal of medicine.